All In Biotech

Drug Trial Radar · NCT06604949

A Study of Single Dose of LP-003 in Healthy Adult Subjects

To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Dose of LP-003 in Healthy Adult Subjects

Last checked: Nov 19, 2026Latest source record: Dec 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

12

Actual

Start

Oct 23, 2024

Primary completion

Nov 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Longbio PharmaIndustry
Sponsor type
Industry
First posted
Sep 20, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate safety, tolerability, immunogenicity, pharmacokinetics, pharmacodynamics, and efficacy of LP-003 in healthy subjects.

Conditions

  • Chronic Spontaneous Urticaria

Interventions

  • LP-003 200mgDrug

    Subcutaneous injection of 200 mg LP-003

  • PlaceboDrug

    Subcutaneous injection of placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of adverse events (AE)Time frame: From the beginning of first patient in (FPI) to the end of study up to approximately 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shanghai General Hospital

    Shanghai, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.